Our FY18/19E numbers assume better NIMs, controlled opex and a fund raise (Rs 4bn QIP at Rs 170/sh). With healthy business momentum and asset quality under control, DCBs recent run-up is sustainable. We remain BUYers of DCBs multi-year growth story with a revised TP of Rs 197 (2.25x Mar-19E ABV of Rs 87.6)